AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
NASDAQ:AXGN
Price:
5.87 USD
0.69%
Market Closed
Updated:
May 9, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
1.7
Current
2.8
Median
2.5
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=1.7
Enterprise Value
/
285.7m
Revenue
163.7m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
AxoGen Inc
NASDAQ:AXGN
|
256.4m USD | 1.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.6B USD | 4.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
134.9B USD | 17.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.4B USD | 6.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.4B USD | 3.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.9B USD | 7.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.5B USD | 4.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 3.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
366B CNY | 10.1 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.5B USD | 13.2 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
1.6
2-Years Forward
EV/S
1.4
3-Years Forward
EV/S
1.2
You don't have any saved screeners yet
